Werner syndrome gene variants in human sarcomas

✍ Scribed by Jessica J. Hsu; Ashwini S. Kamath-Loeb; Eitan Glick; Brett Wallden; Karen Swisshelm; Brian P. Rubin; Lawrence A. Loeb

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 186 KB
• Volume: 49
• Category: Article
• ISSN: 0899-1987
• DOI: 10.1002/mc.20586

✦ Synopsis

Abstract

Werner syndrome is an autosomal inherited disease that is characterized by premature aging. The gene mutated in Werner syndrome (WS), WRN, encodes both a 3′ → 5′ DNA helicase and a 3′ → 5′ DNA exonuclease. Among the WS phenotypes is an exceptionally high incidence of sarcomas. We asked whether spontaneous sarcomas, not known to be associated with WS, also harbor mutations or unreported single nucleotide polymorphisms (SNPs) in WRN. We analyzed RNA or DNA sequences within the helicase and exonuclease domains from 51 and 69 matched sarcoma and adjacent normal tissues, respectively. Among a total of 13 nucleotide variants detected, we identified three novel nonsynonymous substitutions: c.611C>T, c.809_810insT, and c.1882C>G. We further characterized one, c.611C>T, which results in substitution of an evolutionarily conserved proline at amino acid 204 in the exonuclease domain with leucine. We show that P204L WRN exhibits a reduction of WRN exonuclease activity; the specific activity is ∼10‐fold lower than that of wild‐type WRN. In contrast, the helicase activity of P204L WRN is reduced less than twofold. © 2009 Wiley‐Liss, Inc.